Access to Innovation 2019 Agenda


Theme: ‘Innovating for Critical Mass’

*Please note the schedule is subject to change*

 

8.00 – 8.30 Registration, Continental Breakfast & Networking Sponsored by APS and Fasken

8.30 – 8.40 Welcome & Introduction

Nancy Harrison, Chair, Board of Directors, LifeSciences BC

8.40 – 8.45 Government of British Columbia Welcome

Dr. Alan Winter, B.C. Innovation Commissioner

8.45 – 9:15 Keynote: Learning Health Systems in Canada

Dr. Tom Noseworthy, CEO, BC Academic Health Sciences Network (BCAHSN)

9.15 – 9.20 Innovate BC – Morning Sponsor

William Johnson, Director, Marketing & Communications

9.20 – 10.15 Session 1: Healthcare Innovation Strategy

Sponsored By: AstraZeneca & CDRD

Moderator: Gordon McCauley, President & CEO, Centre for Drug Research & Development (CDRD) 

Panellists:

  • Karimah Es Sabar, Chair, Health Bioscience Economic Strategy Table (HBEST) & President & CEO, Quark Venture
  • Neil Fraser, President, Medtronic
  • Joyce Drohan, Partner, Omnia Artificial Intelligence BC Leader, Deloitte Canada

10.15 – 10.30 Session 2: New Patient-Care Discovery

Ohad Arazi, Chief Strategy Officer and Vice President, TELUS Health

10.30 – 11.00 Networking Break Sponsored By: AbCellera

11.00 – 12.00 Session 3: Public – Private Partnerships

Sponsored By: LifeLabs

11.00 – 11.15 Canada’s Digital Technology Supercluster: Program Development and Review

Bill Tam, Co-Founder, VP Business Development and Partnerships, Digital Technology Supercluster

11.15 – 11.30 Innovation for Defence Excellence and Security Program

Christopher Brosinsky, Director, Innovation for Defence Excellence and Security (IDEaS), Department of National Defence, Canadian Armed Forces

11.30 – 11.45 LifeLabs – Strategic Private Partnerships

Jennifer Cudlipp, Senior Vice President B.C., LifeLabs 

11.45 – 12.00 GSK: Partnership Environment Building

Meg Ehm, Senior Scientific Director, Target Sciences Group, GSK

12.00 – 1.00 Lunch Sponsored By: CHÉOS

1.00 – 1.15 Centre for Health Evaluation & Outcome Sciences (CHÉOS)

 Dr. Larry Lynd, Professor, Faculty of Medicine, Rare Diseases, University of British Columbia

1.15 – 1.30 Innovative Medicines Canada (IMC)

Pamela Fralick, President, IMC

1.30 – 2.00 Session 4: Biomedical Innovation

Sponsored By: Michael Smith Foundation for Health Research & St. Paul’s Foundation/Providence

Innovation at Providence Health Care

Dr. Martin Trotter, Department Head, Dermatopathologist, St. Paul’s Hospital

“Traversing the pathway from concept to implementation: a PROOF case study”

Introduction: Dr. Bev Holmes, President & CEO, Michael Smith Foundation for Health Research (MSFHR)

Moderator: Dr. Bruce McManus, Professor Department of Pathology and Laboratory Medicine, UBC

Panellists:

  • Dr. Ji-Young Kim, Assay Development Scientist, PROOF Centre of Excellence
  • Dr. Leslie Grad, Manager, Research Programs, MSFHR
  • Dr. David Granville, Professor, Department of Pathology & Laboratory Medicine, University of British Columbia
  • Dr. Samuel Wadsworth, Co-Founder & CSO, Aspect Biosystems Inc.

2.00 – 2.30 Session 5: The Innovation Imperative – Where Are We Now 

Introduction: Thomas O’Shaughnessy, Partner, Western Leader Health Care, Deloitte Canada

Speaker: Mike Standing, Regional Leader, Life Sciences & Health Care, Europe, Middle East and Africa (EMEA), Deloitte

2.30 – 3.20 Session 6: Pharmacogenomics

Sponsored By: Genome BC

Panel Moderator: Dr. Ellie Griffith, Sector Director, Health, Genome BC

Panellists:

  • Dr. Jehannine Austin, Professor, Psychiatry & Medical Genetics, University of British Columbia
  • Carolyn Bell, Executive Director, BC Ministry of Health
  • Dr. Catalina Lopez-Correa, CSO, Vice President, Sectors, Genome BC
  • Dr. Daniel Mueller, Clinician Scientist & Head, Pharmacogenomics Research Clinic, Campbell Family Mental Health Research Institute
  • Geraldine Vance, CEO, BC Pharmacy Association

3.20 – 3.40 Networking Break Sponsored By: Innovative Medicines Canada

3.40 – 4.20 Session 7: Innovating and Growing Our Companies

Sponsored By: Accel-Rx

Moderator: Elayne Wandler, Director, Partnerships & Program, Accel-Rx

Panellists:

  • Christine Charette, Managing Director and Founder, Scientia Advisors
  • Robert Dawson, Director, Access and Government Relations, Pfizer Canada Inc.
  • Dr. Simon Pimstone, CEO, Xenon Pharmaceuticals
  • Allyson Tighe, Co-founder and Associate, Amplitude Ventures

4.20 – 4.50 Session 8: New Perspectives on Privacy/Security of Data in Health Sponsored By: Roche Canada

 Moderator Dr. Martin Ester, Professor, Computing Science, Simon Fraser University

Panellists:

  • Praveen Gupta, CEO, PHEMI
  • Scott Morrison, CTO, PHEMI
  • Dvorah Richler, Senior Manager, Strategic Partnerships and Policy, Personalized Health Care, Hoffmann-La Roche Limited

4.50 – 5.30 Session 9: Being Bold in Our Innovation

Sponsored By: Zymeworks 

Moderator: Dr. Ali Tehrani, Founder, President & CEO, Zymeworks 

  • Vern Brownell, President & CEO, D-Wave Systems
  • Dr. Carl Hansen, CEO, AbCellera
  • Tamer Mohamed, Co-Founder, President & CEO, Aspect Biosystems 

5.30 – 5.40 Closing Remarks

 Ali Ardakani, Vice-Chair, Board of Directors, LifeSciences BC & Founder & Managing Director, Novateur Ventures

5.40 – 7.00 Networking Reception